Guidelines for preclinical evaluation and clinical trials in osteoporosis 

 - Geneva  World Health Organization  1998 
 - vi, 68p. 
<br/><br/> Provides practical information on how clinical trials in osteoporosis, which is described as a health care problem for ageing communities, are to be carried out. The guidelines presented address pharmacological interventions in osteoporosis with the intention to decrease the risk of fragility fractures because clinical effects of this problem are fractures that can lead to mortality. 
<br/><br/><label>ISBN: </label>92-4-154522-4 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials|Bone Diseases, Metabolic|Osteoporosis|Mortality
<br/><br/><label>LC Class. No.: </label>WE 250 .G8 1998